nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—adrenal cortex—polycystic ovary syndrome	0.0253	0.0686	CbGeAlD
Nelarabine—Sinus headache—Metformin—polycystic ovary syndrome	0.0237	0.112	CcSEcCtD
Nelarabine—DGUOK—endometrium—polycystic ovary syndrome	0.0226	0.0612	CbGeAlD
Nelarabine—DGUOK—uterus—polycystic ovary syndrome	0.0208	0.0564	CbGeAlD
Nelarabine—DGUOK—pituitary gland—polycystic ovary syndrome	0.0204	0.0554	CbGeAlD
Nelarabine—DGUOK—adipose tissue—polycystic ovary syndrome	0.0204	0.0552	CbGeAlD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.0197	0.0489	CbGpPWpGaD
Nelarabine—DGUOK—adrenal gland—polycystic ovary syndrome	0.0183	0.0495	CbGeAlD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0173	0.0427	CbGpPWpGaD
Nelarabine—DGUOK—female gonad—polycystic ovary syndrome	0.017	0.0462	CbGeAlD
Nelarabine—DGUOK—vagina—polycystic ovary syndrome	0.0169	0.0459	CbGeAlD
Nelarabine—DGUOK—endocrine gland—polycystic ovary syndrome	0.0158	0.0429	CbGeAlD
Nelarabine—POLA1—endometrium—polycystic ovary syndrome	0.0139	0.0378	CbGeAlD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.0131	0.0324	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.0127	0.0314	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0126	0.0313	CbGpPWpGaD
Nelarabine—POLA1—pituitary gland—polycystic ovary syndrome	0.0126	0.0342	CbGeAlD
Nelarabine—POLA1—adipose tissue—polycystic ovary syndrome	0.0126	0.034	CbGeAlD
Nelarabine—POLA1—G1/S-Specific Transcription—CDC6—polycystic ovary syndrome	0.0123	0.0305	CbGpPWpGaD
Nelarabine—DCK—embryo—polycystic ovary syndrome	0.0117	0.0318	CbGeAlD
Nelarabine—ADA—adipose tissue—polycystic ovary syndrome	0.0116	0.0316	CbGeAlD
Nelarabine—POLA1—adrenal gland—polycystic ovary syndrome	0.0113	0.0305	CbGeAlD
Nelarabine—POLA1—female gonad—polycystic ovary syndrome	0.0105	0.0285	CbGeAlD
Nelarabine—ADA—adrenal gland—polycystic ovary syndrome	0.0104	0.0283	CbGeAlD
Nelarabine—POLA1—vagina—polycystic ovary syndrome	0.0104	0.0283	CbGeAlD
Nelarabine—Fungal infection—Metformin—polycystic ovary syndrome	0.00999	0.0471	CcSEcCtD
Nelarabine—ADA—vagina—polycystic ovary syndrome	0.00968	0.0262	CbGeAlD
Nelarabine—DCK—adrenal cortex—polycystic ovary syndrome	0.00962	0.0261	CbGeAlD
Nelarabine—POLA1—G1/S-Specific Transcription—RRM2—polycystic ovary syndrome	0.00961	0.0238	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00958	0.0237	CbGpPWpGaD
Nelarabine—Clofarabine—RRM2—polycystic ovary syndrome	0.00946	0.635	CrCbGaD
Nelarabine—Rigors—Metformin—polycystic ovary syndrome	0.00945	0.0446	CcSEcCtD
Nelarabine—Blood disorder—Metformin—polycystic ovary syndrome	0.00924	0.0436	CcSEcCtD
Nelarabine—ADA—endocrine gland—polycystic ovary syndrome	0.00906	0.0246	CbGeAlD
Nelarabine—POLA1—Nucleotide Metabolism—RRM2—polycystic ovary syndrome	0.00879	0.0218	CbGpPWpGaD
Nelarabine—DCK—endometrium—polycystic ovary syndrome	0.00859	0.0233	CbGeAlD
Nelarabine—ADA—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00838	0.0207	CbGpPWpGaD
Nelarabine—DCK—uterus—polycystic ovary syndrome	0.00792	0.0215	CbGeAlD
Nelarabine—POLA1—Activation of the pre-replicative complex—CDC6—polycystic ovary syndrome	0.00782	0.0193	CbGpPWpGaD
Nelarabine—DCK—pituitary gland—polycystic ovary syndrome	0.00777	0.0211	CbGeAlD
Nelarabine—DCK—adipose tissue—polycystic ovary syndrome	0.00774	0.021	CbGeAlD
Nelarabine—ADA—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00726	0.018	CbGpPWpGaD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—CDC6—polycystic ovary syndrome	0.00724	0.0179	CbGpPWpGaD
Nelarabine—Neuropathy—Metformin—polycystic ovary syndrome	0.00724	0.0342	CcSEcCtD
Nelarabine—DCK—adrenal gland—polycystic ovary syndrome	0.00694	0.0188	CbGeAlD
Nelarabine—DCK—female gonad—polycystic ovary syndrome	0.00648	0.0176	CbGeAlD
Nelarabine—DCK—vagina—polycystic ovary syndrome	0.00644	0.0174	CbGeAlD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.00608	0.015	CbGpPWpGaD
Nelarabine—DCK—endocrine gland—polycystic ovary syndrome	0.00602	0.0163	CbGeAlD
Nelarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.00597	0.0148	CbGpPWpGaD
Nelarabine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00574	0.0271	CcSEcCtD
Nelarabine—Lethargy—Metformin—polycystic ovary syndrome	0.00571	0.027	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—CCNE2—polycystic ovary syndrome	0.00567	0.014	CbGpPWpGaD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—RRM2—polycystic ovary syndrome	0.00565	0.014	CbGpPWpGaD
Nelarabine—Pain in extremity—Metformin—polycystic ovary syndrome	0.0056	0.0264	CcSEcCtD
Nelarabine—Cladribine—RRM2—polycystic ovary syndrome	0.00543	0.365	CrCbGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—polycystic ovary syndrome	0.00531	0.0131	CbGpPWpGaD
Nelarabine—Dehydration—Metformin—polycystic ovary syndrome	0.00521	0.0246	CcSEcCtD
Nelarabine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00487	0.023	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00485	0.012	CbGpPWpGaD
Nelarabine—Neutropenia—Metformin—polycystic ovary syndrome	0.00453	0.0213	CcSEcCtD
Nelarabine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00432	0.0204	CcSEcCtD
Nelarabine—Infestation—Metformin—polycystic ovary syndrome	0.00432	0.0204	CcSEcCtD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—CCNB1—polycystic ovary syndrome	0.00429	0.0106	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00423	0.02	CcSEcCtD
Nelarabine—ADA—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.00421	0.0104	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.00408	0.0101	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00408	0.0192	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—YAP1—polycystic ovary syndrome	0.00401	0.00993	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.00388	0.0096	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00385	0.0182	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00384	0.0095	CbGpPWpGaD
Nelarabine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00382	0.018	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.00381	0.00944	CbGpPWpGaD
Nelarabine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00381	0.018	CcSEcCtD
Nelarabine—Eye disorder—Metformin—polycystic ovary syndrome	0.00362	0.0171	CcSEcCtD
Nelarabine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0036	0.017	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00356	0.0088	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00355	0.00878	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.00354	0.00877	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication Pre-Initiation—CDC6—polycystic ovary syndrome	0.00353	0.00874	CbGpPWpGaD
Nelarabine—Angiopathy—Metformin—polycystic ovary syndrome	0.00351	0.0166	CcSEcCtD
Nelarabine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00349	0.0165	CcSEcCtD
Nelarabine—Chills—Metformin—polycystic ovary syndrome	0.00348	0.0164	CcSEcCtD
Nelarabine—Malnutrition—Metformin—polycystic ovary syndrome	0.00337	0.0159	CcSEcCtD
Nelarabine—Dysgeusia—Metformin—polycystic ovary syndrome	0.0033	0.0156	CcSEcCtD
Nelarabine—DGUOK—Metabolism—NMNAT3—polycystic ovary syndrome	0.00321	0.00795	CbGpPWpGaD
Nelarabine—Vision blurred—Metformin—polycystic ovary syndrome	0.00318	0.015	CcSEcCtD
Nelarabine—Tremor—Metformin—polycystic ovary syndrome	0.00316	0.0149	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—CCNB1—polycystic ovary syndrome	0.00316	0.00781	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—BAX—polycystic ovary syndrome	0.00315	0.00779	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.00309	0.00765	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDC6—polycystic ovary syndrome	0.00308	0.00763	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00302	0.00746	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.003	0.00743	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.003	0.00741	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.00299	0.00741	CbGpPWpGaD
Nelarabine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00296	0.014	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—CCNE2—polycystic ovary syndrome	0.00296	0.00733	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LPCAT2—polycystic ovary syndrome	0.00294	0.00727	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SUOX—polycystic ovary syndrome	0.00294	0.00727	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.00289	0.00715	CbGpPWpGaD
Nelarabine—Myalgia—Metformin—polycystic ovary syndrome	0.00287	0.0135	CcSEcCtD
Nelarabine—Chest pain—Metformin—polycystic ovary syndrome	0.00287	0.0135	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—CDC6—polycystic ovary syndrome	0.00278	0.00689	CbGpPWpGaD
Nelarabine—Oedema—Metformin—polycystic ovary syndrome	0.00275	0.013	CcSEcCtD
Nelarabine—Infection—Metformin—polycystic ovary syndrome	0.00273	0.0129	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00273	0.00676	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ISYNA1—polycystic ovary syndrome	0.00273	0.00676	CbGpPWpGaD
Nelarabine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0027	0.0127	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.0027	0.00667	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00269	0.0127	CcSEcCtD
Nelarabine—POLA1—S Phase—CCNE2—polycystic ovary syndrome	0.00269	0.00665	CbGpPWpGaD
Nelarabine—Anorexia—Metformin—polycystic ovary syndrome	0.00262	0.0124	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.0026	0.00644	CbGpPWpGaD
Nelarabine—Hypotension—Metformin—polycystic ovary syndrome	0.00257	0.0121	CcSEcCtD
Nelarabine—POLA1—S Phase—CDC6—polycystic ovary syndrome	0.00253	0.00626	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00251	0.0118	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.0025	0.00618	CbGpPWpGaD
Nelarabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00247	0.0117	CcSEcCtD
Nelarabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00245	0.0116	CcSEcCtD
Nelarabine—Somnolence—Metformin—polycystic ovary syndrome	0.00245	0.0115	CcSEcCtD
Nelarabine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00239	0.0113	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00238	0.0112	CcSEcCtD
Nelarabine—Fatigue—Metformin—polycystic ovary syndrome	0.00237	0.0112	CcSEcCtD
Nelarabine—Constipation—Metformin—polycystic ovary syndrome	0.00235	0.0111	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.00235	0.00581	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TEAD2—polycystic ovary syndrome	0.00232	0.00574	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKR1C2—polycystic ovary syndrome	0.00232	0.00574	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—BAX—polycystic ovary syndrome	0.00232	0.00574	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00227	0.00561	CbGpPWpGaD
Nelarabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00227	0.0107	CcSEcCtD
Nelarabine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00225	0.0106	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.00219	0.00542	CbGpPWpGaD
Nelarabine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00218	0.0103	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—RRM2—polycystic ovary syndrome	0.00217	0.00538	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—RAB2A—polycystic ovary syndrome	0.00213	0.00527	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00209	0.00517	CbGpPWpGaD
Nelarabine—Asthenia—Metformin—polycystic ovary syndrome	0.00197	0.00931	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.00197	0.00488	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PNPLA2—polycystic ovary syndrome	0.00195	0.00481	CbGpPWpGaD
Nelarabine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00188	0.00888	CcSEcCtD
Nelarabine—DGUOK—Metabolism—SRD5A1—polycystic ovary syndrome	0.00184	0.00456	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.00183	0.00453	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00183	0.00452	CbGpPWpGaD
Nelarabine—Dizziness—Metformin—polycystic ovary syndrome	0.00182	0.00858	CcSEcCtD
Nelarabine—DGUOK—Metabolism—STAR—polycystic ovary syndrome	0.00176	0.00435	CbGpPWpGaD
Nelarabine—Vomiting—Metformin—polycystic ovary syndrome	0.00175	0.00825	CcSEcCtD
Nelarabine—Headache—Metformin—polycystic ovary syndrome	0.00172	0.00813	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00169	0.00417	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00166	0.00411	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CCNB1—polycystic ovary syndrome	0.00165	0.00408	CbGpPWpGaD
Nelarabine—Nausea—Metformin—polycystic ovary syndrome	0.00163	0.00771	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.00159	0.00394	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HMMR—polycystic ovary syndrome	0.00157	0.00388	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00154	0.00382	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.00154	0.00382	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—SERPINE1—polycystic ovary syndrome	0.00154	0.00381	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HSD3B1—polycystic ovary syndrome	0.0015	0.0037	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00149	0.0037	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00145	0.00359	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—RAB2A—polycystic ovary syndrome	0.00143	0.00353	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.00139	0.00344	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LHB—polycystic ovary syndrome	0.00136	0.00338	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00136	0.00336	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.00135	0.00333	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HSD3B2—polycystic ovary syndrome	0.00133	0.0033	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKR1C1—polycystic ovary syndrome	0.00129	0.0032	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SULT2A1—polycystic ovary syndrome	0.00119	0.00294	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00117	0.00289	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—RRM2—polycystic ovary syndrome	0.00115	0.00285	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—CDC6—polycystic ovary syndrome	0.00115	0.00285	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00113	0.00279	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—YAP1—polycystic ovary syndrome	0.00111	0.00275	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.00111	0.00274	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NAMPT—polycystic ovary syndrome	0.00107	0.00264	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NMNAT3—polycystic ovary syndrome	0.00107	0.00264	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP11A1—polycystic ovary syndrome	0.00105	0.0026	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKR1C3—polycystic ovary syndrome	0.000994	0.00246	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NMNAT3—polycystic ovary syndrome	0.000984	0.00243	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP17A1—polycystic ovary syndrome	0.000979	0.00242	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SUOX—polycystic ovary syndrome	0.000975	0.00241	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPCAT2—polycystic ovary syndrome	0.000975	0.00241	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000929	0.0023	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000915	0.00226	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000908	0.00225	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ISYNA1—polycystic ovary syndrome	0.000906	0.00224	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SUOX—polycystic ovary syndrome	0.0009	0.00223	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPCAT2—polycystic ovary syndrome	0.0009	0.00223	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000861	0.00213	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAD2L1—polycystic ovary syndrome	0.000848	0.0021	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TH—polycystic ovary syndrome	0.000847	0.0021	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ISYNA1—polycystic ovary syndrome	0.000836	0.00207	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC2A4—polycystic ovary syndrome	0.000824	0.00204	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000819	0.00203	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000809	0.002	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—LMNA—polycystic ovary syndrome	0.000789	0.00195	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP19A1—polycystic ovary syndrome	0.000775	0.00192	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000774	0.00191	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TEAD2—polycystic ovary syndrome	0.000771	0.00191	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKR1C2—polycystic ovary syndrome	0.000771	0.00191	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDC6—polycystic ovary syndrome	0.00077	0.0019	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000729	0.0018	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TEAD2—polycystic ovary syndrome	0.000711	0.00176	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKR1C2—polycystic ovary syndrome	0.000711	0.00176	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GNAS—polycystic ovary syndrome	0.000691	0.00171	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—CCNB1—polycystic ovary syndrome	0.000681	0.00168	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000672	0.00166	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NCOR1—polycystic ovary syndrome	0.000659	0.00163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000646	0.0016	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000635	0.00157	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A1—polycystic ovary syndrome	0.000624	0.00154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000612	0.00151	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—RRM2—polycystic ovary syndrome	0.000601	0.00149	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PNPLA2—polycystic ovary syndrome	0.000596	0.00147	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.00059	0.00146	CbGpPWpGaD
Nelarabine—ADA—Metabolism—STAR—polycystic ovary syndrome	0.000584	0.00145	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MTHFR—polycystic ovary syndrome	0.000582	0.00144	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000567	0.0014	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000566	0.0014	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SRD5A1—polycystic ovary syndrome	0.000565	0.0014	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00054	0.00134	CbGpPWpGaD
Nelarabine—DCK—Metabolism—STAR—polycystic ovary syndrome	0.000539	0.00133	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—LMNA—polycystic ovary syndrome	0.000527	0.0013	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMMR—polycystic ovary syndrome	0.000521	0.00129	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000509	0.00126	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000506	0.00125	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000497	0.00123	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMMR—polycystic ovary syndrome	0.00048	0.00119	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—polycystic ovary syndrome	0.000472	0.00117	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000471	0.00117	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—POMC—polycystic ovary syndrome	0.000465	0.00115	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—INS—polycystic ovary syndrome	0.000463	0.00115	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD3B1—polycystic ovary syndrome	0.000458	0.00113	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000455	0.00113	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LHB—polycystic ovary syndrome	0.000453	0.00112	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000443	0.0011	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000429	0.00106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LHB—polycystic ovary syndrome	0.000418	0.00103	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD3B2—polycystic ovary syndrome	0.000409	0.00101	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKR1C1—polycystic ovary syndrome	0.000396	0.000979	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000395	0.000976	CbGpPWpGaD
Nelarabine—ADA—Metabolism—RRM2—polycystic ovary syndrome	0.000382	0.000945	CbGpPWpGaD
Nelarabine—ADA—Metabolism—YAP1—polycystic ovary syndrome	0.000368	0.000911	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SULT2A1—polycystic ovary syndrome	0.000364	0.000901	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NAMPT—polycystic ovary syndrome	0.000354	0.000876	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000353	0.000872	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RRM2—polycystic ovary syndrome	0.000353	0.000872	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000349	0.000865	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000347	0.000858	CbGpPWpGaD
Nelarabine—DCK—Metabolism—YAP1—polycystic ovary syndrome	0.00034	0.000841	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKR1C3—polycystic ovary syndrome	0.00033	0.000817	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	0.000327	0.000808	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000325	0.000804	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	0.000323	0.000798	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	0.000305	0.000754	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	0.0003	0.000742	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TH—polycystic ovary syndrome	0.000281	0.000696	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000273	0.000677	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TH—polycystic ovary syndrome	0.000259	0.000642	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000257	0.000636	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	0.000252	0.000624	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	0.000237	0.000587	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNAS—polycystic ovary syndrome	0.000229	0.000568	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOR1—polycystic ovary syndrome	0.000219	0.000541	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNAS—polycystic ovary syndrome	0.000212	0.000524	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000207	0.000513	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	0.000202	0.000499	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—polycystic ovary syndrome	0.000193	0.000478	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	0.000191	0.000473	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	0.000178	0.000441	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—polycystic ovary syndrome	0.000157	0.000388	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—polycystic ovary syndrome	0.000155	0.000382	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INS—polycystic ovary syndrome	0.000154	0.00038	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—polycystic ovary syndrome	0.000145	0.000358	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—polycystic ovary syndrome	0.000143	0.000353	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INS—polycystic ovary syndrome	0.000142	0.000351	CbGpPWpGaD
